000 01144 a2200325 4500
005 20250516060148.0
264 0 _c20120604
008 201206s 0 0 eng d
022 _a1365-2346
024 7 _a10.1097/EJA.0b013e32834c7c9d
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGinz, Hans F
245 0 0 _aDantrolene for severe rhabdomyolysis in Staphylococcus aureus toxic shock syndrome.
_h[electronic resource]
260 _bEuropean journal of anaesthesiology
_cMar 2012
300 _a161-2 p.
_bdigital
500 _aPublication Type: Case Reports; Letter
650 0 4 _aDantrolene
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aRhabdomyolysis
_xdrug therapy
650 0 4 _aShock, Septic
_xcomplications
650 0 4 _aStaphylococcal Infections
_xcomplications
700 1 _aLevano, Soledad
700 1 _aGirard, Thierry
700 1 _aUrwyler, Albert
700 1 _aHamel, Christian
773 0 _tEuropean journal of anaesthesiology
_gvol. 29
_gno. 3
_gp. 161-2
856 4 0 _uhttps://doi.org/10.1097/EJA.0b013e32834c7c9d
_zAvailable from publisher's website
999 _c21204857
_d21204857